These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36246085)

  • 21. Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county.
    Suwabe T; Chamberlain AM; Killian JM; King BF; Gregory AV; Madsen CD; Wang X; Kline TL; Chebib FT; Hogan MC; Kamath PS; Harris PC; Torres VE
    JHEP Rep; 2020 Dec; 2(6):100166. PubMed ID: 33145487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
    Senum SR; Li YSM; Benson KA; Joli G; Olinger E; Lavu S; Madsen CD; Gregory AV; Neatu R; Kline TL; Audrézet MP; Outeda P; Nau CB; Meijer E; Ali H; Steinman TI; Mrug M; Phelan PJ; Watnick TJ; Peters DJM; Ong ACM; Conlon PJ; Perrone RD; Cornec-Le Gall E; Hogan MC; Torres VE; Sayer JA; ; Harris PC
    Am J Hum Genet; 2022 Jan; 109(1):136-156. PubMed ID: 34890546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.
    Martin WP; Vaughan LE; Yoshida K; Takahashi N; Edwards ME; Metzger A; Senum SR; Masyuk TV; LaRusso NF; Griffin MD; El-Zoghby Z; Harris PC; Kremers WK; Nagorney DM; Kamath PS; Torres VE; Hogan MC
    Mayo Clin Proc Innov Qual Outcomes; 2019 Jun; 3(2):149-159. PubMed ID: 31193902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China.
    Xue C; Zhou CC; Wu M; Mei CL
    Kidney Dis (Basel); 2016 Oct; 2(3):111-119. PubMed ID: 27921038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait.
    Ali H; Naim M; Senum SR; AlSahow A; Bahbahani Y; Abu-Farha M; Abubaker J; Mohammad A; Al-Hunayan A; Asbeutah AM; Zayed M; Devarajan S; Hussain N; John SE; Channanath A; Thanaraj TA; Al-Ali M; AlMousawi M; Al-Mulla F; Harris PC
    Clin Kidney J; 2023 Feb; 16(2):355-366. PubMed ID: 36755831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical genetic diagnostics in Danish autosomal dominant polycystic kidney disease patients reveal possible founder variants.
    Nielsen ML; Lildballe DL; Rasmussen M; Bojesen A; Birn H; Sunde L
    Eur J Med Genet; 2021 Apr; 64(4):104183. PubMed ID: 33639313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease.
    Kataoka H; Watanabe S; Sato M; Manabe S; Makabe S; Akihisa T; Ushio Y; Iwasa N; Yoshida R; Tsuchiya K; Nitta K; Mochizuki T
    Hepatol Int; 2021 Jun; 15(3):791-803. PubMed ID: 33811288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families.
    Mantovani V; Bin S; Graziano C; Capelli I; Minardi R; Aiello V; Ambrosini E; Cristalli CP; Mattiaccio A; Pariali M; De Fanti S; Faletra F; Grosso E; Cantone R; Mancini E; Mencarelli F; Pasini A; Wischmeijer A; Sciascia N; Seri M; La Manna G
    Front Genet; 2020; 11():464. PubMed ID: 32457805
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular Mechanisms of Isolated Polycystic Liver Diseases.
    Yu Z; Shen X; Hu C; Zeng J; Wang A; Chen J
    Front Genet; 2022; 13():846877. PubMed ID: 35571028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of a novel
    Wang J; Yang H; Guo R; Sang X; Mao Y
    Ann Transl Med; 2021 Jan; 9(2):120. PubMed ID: 33569422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics and mechanisms of hepatic cystogenesis.
    van de Laarschot LFM; Drenth JPH
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1491-1497. PubMed ID: 28782656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.
    Cnossen WR; Maurits JS; Salomon J; Te Morsche RH; Waanders E; Drenth JP
    J Clin Lab Anal; 2016 Sep; 30(5):431-6. PubMed ID: 26365003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial.
    D'Agnolo HM; Kievit W; Takkenberg RB; Riaño I; Bujanda L; Neijenhuis MK; Brunenberg EJ; Beuers U; Banales JM; Drenth JP
    J Hepatol; 2016 Sep; 65(3):601-7. PubMed ID: 27212247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.
    D'Agnolo HMA; Casteleijn NF; Gevers TJG; de Fijter H; van Gastel MDA; Messchendorp AL; Peters DJM; Salih M; Soonawala D; Spithoven EM; Visser FW; Wetzels JFM; Zietse R; Gansevoort RT; Drenth JPH
    Am J Nephrol; 2017; 46(3):239-248. PubMed ID: 28881341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies.
    Lanktree MB; Haghighi A; di Bari I; Song X; Pei Y
    Clin J Am Soc Nephrol; 2021 May; 16(5):790-799. PubMed ID: 32690722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of Seminal Megavesicles, Prostate Median Cysts, and Genotype in Autosomal Dominant Polycystic Kidney Disease.
    Zhang W; Stephens CJ; Blumenfeld JD; Behzadi AH; Donahue S; Bobb WO; Newhouse JH; Rennert H; Zhao Y; Prince MR
    J Magn Reson Imaging; 2019 Mar; 49(3):894-903. PubMed ID: 30230107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation.
    Peces R; Drenth JP; Te Morsche RH; González P; Peces C
    World J Gastroenterol; 2005 Dec; 11(48):7690-3. PubMed ID: 16437702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel GANAB variants associated with polycystic liver disease.
    van de Laarschot LFM; Te Morsche RHM; Hoischen A; Venselaar H; Roelofs HM; Cnossen WR; Banales JM; Roepman R; Drenth JPH
    Orphanet J Rare Dis; 2020 Oct; 15(1):302. PubMed ID: 33097077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.